Tumor Registry of Lymphatic Neoplasia
NCT00889798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3795
Last updated 2020-05-18
Summary
The purpose of this registry is to record information on therapy reality of malignant lymphatic systemic diseases by office-based haematologists in Germany.
Conditions
- Non-Hodgkin's Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL)
- Multiple Myeloma (MM)
Sponsors & Collaborators
-
iOMEDICO AG
lead INDUSTRY
Principal Investigators
-
Wolfgang Knauf, MD · Center for Haematology, Frankfurt, Germany
-
Wolfang Abenhardt, MD · MVZ Onkologie im Elisenhof, München, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2019-08-31
- Completion
- 2019-08-31
More Related Trials
-
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
NCT00199017 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00147953 ·Status: COMPLETED ·Phase: PHASE2
-
Bergamo Lymphoid Cancer Registry
NCT03131531 ·Status: RECRUITING
-
Identification of Occupational Exposures in Acute Hematologic Malignancy
NCT03316209 ·Status: COMPLETED
-
Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant Lymphomas
NCT00685997 ·Status: COMPLETED
-
Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia
NCT05832125 ·Status: UNKNOWN
-
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
NCT06043011 ·Status: RECRUITING
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
NCT00209209 ·Status: UNKNOWN ·Phase: PHASE3
-
Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study
NCT04982471 ·Status: TERMINATED
-
Brazilian Network for Lymphoma Registry
NCT02265497 ·Status: RECRUITING
-
AGMT Austrian Lymphoma Registry
NCT06294652 ·Status: RECRUITING
-
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
NCT06424379 ·Status: ACTIVE_NOT_RECRUITING
-
Study of LY2835219 for Mantle Cell Lymphoma
NCT01739309 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL
NCT00209222 ·Status: UNKNOWN ·Phase: PHASE3
-
Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults
NCT00199082 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma
NCT05868395 ·Status: RECRUITING ·Phase: PHASE2
-
Brazilian Prospective Hodgkin Lymphoma Registry
NCT02589548 ·Status: UNKNOWN
-
Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy
NCT03054883 ·Status: COMPLETED
-
Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas
NCT04520529 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
NCT00053092 ·Status: COMPLETED ·Phase: PHASE2
-
Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
NCT01011920 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
NCT04882475 ·Status: ACTIVE_NOT_RECRUITING
-
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
NCT02983097 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years
NCT00285389 ·Status: COMPLETED ·Phase: PHASE2